Showing results (521-530 of 541) with videos related to

Sort By:
Pageof 55
Liver Cancer|October 30, 2023
Achievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept StudyMasatoshi Kudo, Tomoko Aoki, Kazuomi Ueshima, et al.
Liver Cancer|October 30, 2023
Impact of Intrahepatic External Beam Radiotherapy in Advanced Hepatocellular Carcinoma Patients Treated with Tyrosine Kinase InhibitorsMyung Ji Goh, Hee Chul Park, Jeong Il Yu, et al.
Liver Cancer|October 30, 2023
Survival Trends in Sorafenib for Advanced Hepatocellular Carcinoma: A Reconstructed Individual Patient Data Meta-Analysis of Randomized TrialsDarren Jun Hao Tan, Ansel Shao Pin Tang, Wen Hui Lim, et al.
Liver Cancer|August 21, 2023
Relationship of Atezolizumab plus Bevacizumab Treatment with Muscle Volume Loss in Unresectable Hepatocellular Carcinoma Patients: Multicenter AnalysisAtsushi Hiraoka, Takashi Kumada, Toshifumi Tada, et al.
Liver Cancer|August 18, 2023
Definitive Liver Radiotherapy for Intrahepatic Cholangiocarcinoma with Extrahepatic MetastasesBrian De, Rituraj Upadhyay, Kaiping Liao, et al.
Liver Cancer|February 26, 2026
Dynamic FIB-4 Score Changes and HCC Risk in Patients with MASLD and Elevated Liver Enzymes: A Nationwide Cohort StudyYee Hui Yeo, Hsiu J Ho, Tsai-Wei Huang, et al.
Liver Cancer|April 17, 2026
Survival Outcomes, Recurrence Patterns, and Its Corresponding Therapeutic Management after Conversion Therapy Followed by Curative Resection for Hepatocellular Carcinoma: A Real-World StudyRui Xiao, Zhenyun Yang, Zehao Zheng, et al.
Liver Cancer|May 11, 2026
Characterization of Patients with Unresectable Hepatocellular Carcinoma in REFLECT Who Achieved Tumor Response or Alpha-Fetoprotein Response When Treated with LenvatinibAmit Mahipal, Ann-Lii Cheng, Masatoshi Kudo, et al.
Liver Cancer|April 27, 2026
Oncological Outcomes and Treatment Strategies for Borderline Resectable Hepatocellular Carcinoma Based on the Oncological Resectability ClassificationTakashi Hamada, Akihiko Soyama, Hajime Matsushima, et al.
Liver Cancer|May 7, 2026
Clinical Prediction of Glycolysis-Driven Molecular Subclass of Hepatocellular Carcinoma without Transcriptomic ProfilingTomoko Aoki, Masatoshi Kudo, Satoshi Ogiso, et al.
Pageof 55